1. Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study. (June 2017) Authors: Hack, Carolin C.; Fasching, Peter A.; Fehm, Tanja; de Waal, Johann; Rezai, Mahdi; Baier, Bernd; Baake, Gerold; Kolberg, Hans-Christian; Guggenberger, Martin; Warm, Mathias; Harbeck, Nadia; Wuerstlein, Rachel; Deuker, Jörg-Uwe; Dall, Peter; Richter, Barbara; Wachsmann, Grischa; Brucker, Cosima; Si... Journal: Integrative cancer therapies Issue: Volume 16:Number 2(2017:Jun.) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2). (October 2021) Authors: Möbus, Volker; Lück, Hans-Joachim; Ladda, Ekkehart; Klare, Peter; Schmidt, Marcus; Schneeweiss, Andreas; Grischke, Eva-Maria; Wachsmann, Grischa; Forstbauer, Helmut; Untch, Michael; Marmé, Frederik; Blohmer, Jens-Uwe; Jackisch, Christian; Huober, Jens; Stickeler, Elmar; Reinisch, Mattea; Link, Th... Journal: European journal of cancer Issue: Volume 156(2021) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗